Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports ...
Multiple system atrophy (MSA) is an adult-onset, rapidly progressive neurodegenerative disorder characterised by the aggregation of α-synuclein in oligodendroglial cytoplasmatic inclusions.1 ...
Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program - - Positive feedback supports readiness for Phase 3 initiation with manufacturing ...
Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports readiness for Phase 3 initiation with manufacturing scale ...
BioArctic shares fell about 5% on Tuesday after Goldman Sachs cut the stock to "neutral" from "buy," saying recent gains have narrowed upside to its revised 12-month price target of SEK355, down from ...
ATH434 reduced functional decline vs placebo at Week 52 on MuSyCA, a newly described MSA composite scale -- Effects seen on both daily function ...
New NIHR Translational Research Collaboration launched in Parkinson's disease: United Kingdom Monday, April 27, 2026, 12:00 Hrs [IST] The NIHR is expanding its Translational Resea ...
As of Tuesday, April 21, Alterity Therapeutics Limited’s ATHE share price has dipped by 8.54%, which has investors ...
Cenrifki prevents MS disease progression and Itvisma delivers a healthy gene-to-cell nuclei, addressing the root cause of SMA.
The Parkinson’s disease Translational Research Collaboration (PD-TRC), funded by the National Institute for Health and Care ...
The S&P/ASX 200 has slid on Monday as Iran-US talks stall and push oil futures. Meanwhile buoyant Chinese lithium prices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results